CAMPENNI', Alfredo
 Distribuzione geografica
Continente #
EU - Europa 18.640
NA - Nord America 11.085
AS - Asia 6.922
SA - Sud America 2.345
AF - Africa 221
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 13
Totale 39.245
Nazione #
US - Stati Uniti d'America 10.864
RU - Federazione Russa 7.509
IT - Italia 4.989
SG - Singapore 2.824
BR - Brasile 2.033
CN - Cina 1.923
IE - Irlanda 1.650
SE - Svezia 1.588
HK - Hong Kong 797
DE - Germania 649
FR - Francia 491
VN - Vietnam 405
FI - Finlandia 354
NL - Olanda 335
GB - Regno Unito 328
UA - Ucraina 303
IN - India 293
PL - Polonia 119
BD - Bangladesh 105
AR - Argentina 102
CA - Canada 100
TR - Turchia 85
IQ - Iraq 78
ZA - Sudafrica 76
MX - Messico 73
CZ - Repubblica Ceca 59
PK - Pakistan 53
BE - Belgio 50
JP - Giappone 48
AT - Austria 47
EC - Ecuador 45
CO - Colombia 38
UZ - Uzbekistan 37
ES - Italia 36
ID - Indonesia 35
MA - Marocco 33
CL - Cile 32
CI - Costa d'Avorio 31
VE - Venezuela 29
SA - Arabia Saudita 26
IR - Iran 23
AE - Emirati Arabi Uniti 22
LT - Lituania 22
AZ - Azerbaigian 21
PY - Paraguay 20
UY - Uruguay 19
CH - Svizzera 18
KE - Kenya 18
TN - Tunisia 18
PE - Perù 16
AU - Australia 15
DZ - Algeria 14
KZ - Kazakistan 14
EG - Egitto 13
PH - Filippine 13
IL - Israele 11
NP - Nepal 11
PS - Palestinian Territory 11
DO - Repubblica Dominicana 10
JO - Giordania 10
KG - Kirghizistan 10
OM - Oman 10
PA - Panama 10
AL - Albania 9
BO - Bolivia 9
BG - Bulgaria 8
LB - Libano 8
RO - Romania 8
BY - Bielorussia 7
HU - Ungheria 7
NO - Norvegia 7
PT - Portogallo 7
CR - Costa Rica 6
EU - Europa 6
GE - Georgia 6
LV - Lettonia 6
MY - Malesia 6
RS - Serbia 6
XK - ???statistics.table.value.countryCode.XK??? 6
DK - Danimarca 5
GR - Grecia 5
JM - Giamaica 5
TH - Thailandia 5
EE - Estonia 4
GT - Guatemala 4
HN - Honduras 4
HR - Croazia 4
QA - Qatar 4
AM - Armenia 3
BH - Bahrain 3
BN - Brunei Darussalam 3
KR - Corea 3
LK - Sri Lanka 3
MU - Mauritius 3
NG - Nigeria 3
NI - Nicaragua 3
SN - Senegal 3
AO - Angola 2
DM - Dominica 2
ET - Etiopia 2
Totale 39.206
Città #
Moscow 2.161
Dublin 1.646
Ashburn 1.568
Singapore 1.543
Dallas 1.389
Chandler 1.381
Nyköping 862
Hong Kong 792
Beijing 716
Jacksonville 664
San Jose 448
Milan 444
The Dalles 391
Rome 382
Messina 307
Princeton 275
Lauterbourg 253
Los Angeles 251
Dearborn 246
Medford 240
Munich 239
New York 213
Cambridge 204
Des Moines 200
Ann Arbor 186
Naples 174
São Paulo 160
Boardman 129
Buffalo 125
Ho Chi Minh City 108
Hyderabad 97
Warsaw 96
Turku 94
Turin 92
Bremen 91
Jinan 91
Lancaster 85
Pune 84
Redondo Beach 82
Bari 81
Bologna 80
Catania 80
Palermo 80
Tianjin 80
Hanoi 76
Wilmington 73
Guangzhou 67
Florence 63
Dong Ket 61
Woodbridge 60
Belo Horizonte 56
Rio de Janeiro 55
San Mateo 55
Frankfurt am Main 54
Nanjing 53
Shenyang 53
Helsinki 51
Brussels 50
Council Bluffs 50
Genoa 49
Orem 48
Johannesburg 44
Brasília 43
Santa Clara 42
Denver 41
London 40
Brooklyn 39
Montreal 37
Houston 36
Tokyo 36
Zhengzhou 35
Ningbo 34
Chennai 33
Porto Alegre 32
Seattle 32
Stockholm 32
Tashkent 31
Abidjan 30
Brno 30
Chicago 29
Vienna 29
Atlanta 28
Shenzhen 28
Hebei 27
Trieste 27
Nanchang 26
Baghdad 25
Brescia 25
Cagliari 25
Changsha 25
Curitiba 25
Modena 25
Guarulhos 24
Haikou 24
Hangzhou 24
Salvador 24
Falls Church 23
Nuremberg 23
Pisa 22
Taizhou 22
Totale 21.061
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 4.565
EMIAGENESIA TIROIDEA, MORBO DI BASEDOW-GRAVES E CARCINOMA DIFFERENZIATO DELLA TIROIDE: UN’ASSOCIAZIONE MOLTO RARA. 323
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology 269
131I RADIOIODINE THERAPY (RIT) OF HYPERTYROIDISM DUE TO GRAVES’ DISEASE (GD) OR UNI-MULTINODULAR TOXIC GOITER (NTG): OUR EXPERIENCE 254
131I Radioiodine therapy (RIT) of hyperthyroidism due to Graves' disease (GD) or uni-multinodular toxic goiter (NTG): our experience 244
Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy 234
Abscesualized gliomas:predictive value of 99Tc-Leukoscan 228
HYPERPARATHYROIDISM FROM MEDIASTINAL PARATIROID ADENOMA. CASE REPORT. 204
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 204
A didactic experiment showing the Compton scattering by means of a clinical gamma camera 201
99mTc-HM-PAO SPECT evaluation of regional cerebral blood flow modifications after paediatric hydrocephalus shunting 198
99mTc-MIBI SPECT in the differential diagnosis of brain metastases 198
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 198
An analytical model for improving absorbed dose calculation accuracy in non spherical autonomous functioning thyroid nodule 196
2 years-survival analysis of patients with non-small cell lung cancer by means of 2deoxy-2-[18F]fluoro-D-glucose positron emission tomography: implications of maximum standardized uptake value (SUVmax) 196
Abnormal 99mTc-MIBI Uptakein left lung mimicking a neoplastic lesion in a young woman with nodular goiter. A rare pitfall of 99mTc-MIBI 196
Cell proliferation parameters and apoptosis indices in pituitary macroadenomas 190
Abnormal radioiodine uptake on post-therapy whole body scan and sodium/iodine symporter expression in a dermoid cyst of the ovary: report of a case and review of the literature 190
Association of autonously functioning ("hot") thyroid nodules with Hashimotos' thyroiditis (HT). 188
AN UNUSUAL CASE OF MARINE-LENHART SYNDROME. 187
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 187
99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 187
ABLAZIONE RADIOMETABOLICA DEL RESIDUO TIROIDEO POST-CHIRURGICO DOPO STIMOLO CON TSH UMANO RICOMBINANTE (rhTSH) IN PAZIENTI CON OFTALMOPATIA DI GRAVES (OG) DI GRADO MODERATAMENTE SEVERO E SEVERO: STUDIO PROSPETTICO RANDOMIZZATO IN SINGOLO CIECO 186
Association of parathyroid carcinoma and thyroid disorders: A clinical review 185
Abnormal radioiodine uptake in an abdominal dermoid cyst in a patient affected by differentiated thyroid cancer 181
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 181
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 180
ACCUMULO DI TECNEZIO IN METASTASI POLMONARI DA CARCINOMA DIFFERENZIATO TIROIDEO (CDT): UNA RARA EVENIENZA 178
Accidental discovery of lung metastases from differentiated thyroid cancer by 99mTc sodium pertechnetate scan in a patient with secondary hyperparathyroidism 178
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 178
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 177
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 177
ANALYSIS OF THE FACTORS CONDITIONING THE CLINICAL COURSE OF DIFFERENTIATED THYROID CARCINOMA IN CHILDREN AND YOUNG ADULTS 176
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients 174
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 170
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 170
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 170
A simplified method for kidney dosimetry in Lu-177 therapies based on single SPECT-CT and multiple external probe measurements 170
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low risk differentiated thyroid cancer? 169
HER2 analysis in sporadic thyroid cancer of follicular cell origin 169
Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism 169
ACCUMULO DI RADIOIODIO IN MIELOMENINGOCELE SECONDARIO A SPINA BIFIDA OCCULTA: PRIMA EVIDENZA DI CONDIZIONE SIMULANTE UNA METASTASI VERTEBRALE DI CARCINOMA DIFFERENZIATO DELLA TIROIDE 168
Association of primary hyperparathyoidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service. 167
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG) 167
Aplotipi del microsatellite D7S6440, localizzato nell'introne 9 del gene HIPK2, come marcatori molecolari della tiroidite di Hashimoto 167
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy ina real life scenario 166
A model to evaluate S values for beta-gamma emitting radionuclides in cubic voxels 165
Oxidative stress as a key feature of autoimmune thyroiditis: an update 165
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy 164
Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis 164
Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis 163
Association of autonomously functioning thyroid nodules (AFTNs) with Hashimoto's thyroiditis (HT) 162
Abla zione radiometabolica dopo rhTSH del residuo tiroideo post -chirurgico in pazienti con orbitopatia di Graves moderatamente severa e severa 161
Association between primary hyperprathyroidism (p-hyperPTH) and nodular toxic goiter (NTG): a prospective study at an outpatient service for osteoporosis 160
Clinical usefulness of 99mTc-MIBI scintigraphy in the postsurgical evaluation of patients with differentiated thyroid cancer 160
ATYPICAL PRESENTATION OF PARATHYROID CARCINOMA (PC): REPORT OF TWO CASES 159
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes 158
GASTROINTESTINAL SEQUELAE IN SURVIVORS OF CONGENITAL DIAPHRAGMATIC HERNIA 157
FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA PRESENTING AS A TOXIC NODULE IN AN ADOLESCENT GIRL 157
Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by hashimoto's thyroiditis 157
Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence 156
ASSOCIATION OF PRIMARY HYPERPARATHYROIDISM (P-HYPERPTH) WITH NODULAR TOXIC GOITER (NTG): A PROSPECTIVE STUDY AT AN OUTPATIENT OSTEOPOROSIS SERVICE 155
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low-risk differentiated thyroid cancer? 155
Evaluation Of Absorbed Doses To Autonomous Thyroid Nodules During 131I Treatment Of Hyperthyroidism: Traditional Approach Versus Monte Carlo Calculation 154
Hyperthyroidism treatment with calculated activity of 131–radioiodine 154
Internal Dosimetry of Ellipsoidal Targets: models and applications 153
An uncommon case of Marine-Lenhart syndrome 153
Associazione tra noduli tiroidei iperfunzionanti (noduli "caldi") e tiroidite di Hashimoto 152
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service 152
Association of autonomously functioning thyroid nodules with Hashimoto’s thyroiditis: study on a large series of patients 152
A model for computing absorbed fractions for alpha particles in ellipsoidal volumes 151
I livelli sierici del recettore solubile per i prodotti avanzati di glicazione sono ridotti in pazienti pediatrici con tiroidite di Hashimoto 151
Iodine-131 treatment of hyperthyroidism: our experience 150
BRAFV600E and 99mTc-MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy 150
PRRT retreatments: renal function evaluation 149
Hashimoto's thyroiditis is a frequent association of primary hyperparathyroidism, of which it modifies biochemical and bone density indices 148
Supra-Acetabular Brown Tumor due to Primary Hyperparathyroidism Associated with Chronic Renal Failure 148
La paratiroidectomia radioguidata 148
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 148
IODINE-131 TREATMENT OF HYPERTHYROIDISM:OUR EXPERIENCE. 147
BRAF and RAS mutations in differentiated thyroid cancer of patients with low-risk to intermediate-risk treated with radioiodine therapy 147
Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer 147
Association of autonomously functioning ("hot") thyroid nodules with Hashimoto's thyroiditis 146
Is %ΔSUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer? 146
Effetto proinfiammatorio degli oligosaccaridi dell'acido ialuronico in tireociti e fibroblasti umani: ruolo dei recettori tool-like di tipo 2(TLR-2) e 4(TLR-4) 146
Meningocele due to closed spina bifida mimicking a metastasis of papillary thyroid carcinoma on whole body radioactive iodine scan 146
Differentiated thyroid carcinoma in lingual thyroid 145
Hashimoto's thyroiditis (HT) is a frequent association of primary hyperparathyroidism (p-hyperPTH), of which it modifies biochemical and bone density indices 144
Scintigraphic evaluation of colonic motility in patients with anorectal malformations and constipation 144
Meningocele mimicking a metastasis of papillary thyroid carcinoma 144
Geriatric primary hyper-parathyrodism 143
An User-Friendly Approach to the Evaluation of Skin and Eye Lens Doses to the Operators in Nuclear Medicine through Dedicated Monte Carlo Simulations in GAMOS 143
Advances in Monte Carlo patient-specific internal dosimetry for 90 Y-TARE treatments. 142
ATYPICAL PRESENTATION OF PARATHYROID CARCINOMA (PC): REPORT OF TWO CASES 142
Hepatocyte growth factor/C-met axis in thyroid cancer: From diagnostic biomarker to therapeutic target 142
Cystic Fibrosis as a Cause of Malabsorption and Increased Requirement of Levothyroxine 142
I carcinomi tiroidei differenziati. 141
Comment on “Prevalence of undifferentiated inflammatory arthropathy in patients with Hashimoto's thyroiditis in an endocrinology clinic” by Luis M. Valderrama-Hinds and co-workers. Int J Rheum Dis 2019; 22: 1985-1989 141
Importanza del campionamento precoce del TSH, basale e stimolato dal TRH, nell'ipotiroidismo subclinico 140
High grade gliomas associated with abscess: description of two rare cases and role of 99mTc-Leukoscan 140
Totale 21.359
Categoria #
all - tutte 117.650
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.650


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021453 0 0 0 0 0 0 0 0 0 163 158 132
2021/20221.921 22 247 27 74 62 23 103 100 32 318 283 630
2022/20235.160 395 526 245 381 402 575 78 303 2.006 40 150 59
2023/20242.469 116 181 145 202 162 425 123 150 99 295 192 379
2024/20258.397 312 217 314 595 497 372 387 1.565 1.634 559 741 1.204
2025/202617.482 1.008 1.202 1.418 1.173 1.461 3.739 2.149 2.244 2.312 776 0 0
Totale 39.777